113.74
                                            전일 마감가:
              $113.76
            열려 있는:
              $112.76
            하루 거래량:
                728.53K
            Relative Volume:
              1.21
            시가총액:
                $7.55B
            수익:
              $136.86M
            순이익/손실:
              $-168.69M
            주가수익비율:
              -40.48
            EPS:
                -2.81
            순현금흐름:
                $-113.49M
            1주 성능:
              +1.96%
            1개월 성능:
              +14.87%
            6개월 성능:
                +77.69%
            1년 성능:
              +132.08%
            Rhythm Pharmaceuticals Inc Stock (RYTM) Company Profile
명칭
                  
                      Rhythm Pharmaceuticals Inc
                    
                전화
                  
                      857-264-4280
                    
                주소
                  
                      222 BERKELEY STREET, BOSTON, MA
                    
                RYTM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                RYTM
                            
                             
                        Rhythm Pharmaceuticals Inc 
                           | 
                    113.74 | 7.56B | 136.86M | -168.69M | -113.49M | -2.81 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Rhythm Pharmaceuticals Inc Stock (RYTM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 | 
|---|---|---|---|
| 2025-07-10 | 개시 | Goldman | Buy | 
| 2025-07-07 | 개시 | Leerink Partners | Outperform | 
| 2025-04-07 | 업그레이드 | BofA Securities | Neutral → Buy | 
| 2025-03-05 | 재개 | Stifel | Buy | 
| 2025-01-02 | 개시 | Jefferies | Buy | 
| 2024-12-20 | 개시 | Oppenheimer | Outperform | 
| 2024-10-21 | 개시 | Guggenheim | Buy | 
| 2024-09-18 | 개시 | H.C. Wainwright | Buy | 
| 2024-09-17 | 개시 | JMP Securities | Mkt Outperform | 
| 2024-05-08 | 다운그레이드 | BofA Securities | Buy → Neutral | 
| 2023-12-19 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight | 
| 2023-08-01 | 업그레이드 | BofA Securities | Neutral → Buy | 
| 2023-01-18 | 재개 | Canaccord Genuity | Buy | 
| 2022-08-08 | 업그레이드 | Goldman | Neutral → Buy | 
| 2022-08-05 | 업그레이드 | BofA Securities | Underperform → Neutral | 
| 2022-06-17 | 재확인 | Needham | Buy | 
| 2022-03-02 | 재개 | Stifel | Buy | 
| 2022-02-17 | 업그레이드 | Ladenburg Thalmann | Neutral → Buy | 
| 2021-12-08 | 개시 | Wells Fargo | Overweight | 
| 2021-11-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight | 
| 2021-09-14 | 재개 | Goldman | Neutral | 
| 2021-08-04 | 다운그레이드 | BofA Securities | Neutral → Underperform | 
| 2021-08-04 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral | 
| 2020-11-30 | 다운그레이드 | BofA Securities | Buy → Neutral | 
| 2020-01-08 | 개시 | Goldman | Sell | 
| 2019-07-12 | 업그레이드 | Stifel | Hold → Buy | 
| 2019-07-08 | 개시 | Canaccord Genuity | Buy | 
| 2019-03-13 | 개시 | Ladenburg Thalmann | Buy | 
| 2018-09-07 | 재개 | Morgan Stanley | Overweight | 
| 2018-06-25 | 재확인 | Needham | Buy | 
| 2018-06-15 | 재확인 | Needham | Buy | 
| 2017-10-30 | 개시 | BofA/Merrill | Buy | 
| 2017-10-30 | 개시 | Needham | Buy | 
                    모두보기
                    
                  
                Rhythm Pharmaceuticals Inc 주식(RYTM)의 최신 뉴스
Rhythm Pharma Q3 product revenue up 54% yr/yr on IMCIVREE sales - MarketScreener
Rhythm Pharmaceuticals Reports Third Quarter 2025 Financial Results and Business Update - GlobeNewswire
Why retail investors favor Rhythm Pharmaceuticals Inc. stockMarket Growth Report & Expert Approved Momentum Trade Ideas - newser.com
Will Rhythm Pharmaceuticals Inc. price bounce be sustainableWeekly Earnings Recap & Low Volatility Stock Suggestions - newser.com
Is it time to cut losses on Rhythm Pharmaceuticals Inc.Market Trend Review & Community Shared Stock Ideas - newser.com
Can Rhythm Pharmaceuticals Inc. stock weather global recessionWeekly Stock Summary & Daily Volume Surge Signals - newser.com
Rhythm Pharmaceuticals Q3 2025 Earnings Preview - MSN
Will Rhythm Pharmaceuticals Inc. stock benefit from automationQuarterly Trade Summary & High Win Rate Trade Tips - newser.com
How resilient is Rhythm Pharmaceuticals Inc. stock in market downturnsWeekly Trade Review & Free Fast Entry Momentum Trade Alerts - newser.com
Is Rhythm Pharmaceuticals Inc. (1RV) stock supported by free cash flowJuly 2025 Breakouts & Long Hold Capital Preservation Plans - newser.com
Can machine learning forecast Rhythm Pharmaceuticals Inc. recoveryLong Setup & Weekly Top Performers Watchlists - newser.com
Can Rhythm Pharmaceuticals Inc. (1RV) stock hold up in economic slowdownCPI Data & Weekly Return Optimization Plans - newser.com
Is Rhythm Pharmaceuticals Inc. stock positioned for digital transformationWeekly Gains Summary & Step-by-Step Swing Trade Plans - newser.com
Visualizing Rhythm Pharmaceuticals Inc. stock with heatmapsPortfolio Performance Report & Pattern Based Trade Signal System - newser.com
Is a relief rally coming for Rhythm Pharmaceuticals Inc. holdersJuly 2025 Institutional & Consistent Profit Alerts - newser.com
How currency fluctuations impact Rhythm Pharmaceuticals Inc. stockWeekly Risk Summary & Safe Capital Growth Stock Tips - newser.com
Published on: 2025-11-02 22:26:41 - newser.com
Is Rhythm Pharmaceuticals Inc. reversing from oversold territoryLayoff News & Free Long-Term Investment Growth Plans - newser.com
Rhythm Pharmaceuticals Hits New 52-Week High of $116.00 - Markets Mojo
Rhythm Pharmaceuticals, Inc. $RYTM Shares Sold by State of New Jersey Common Pension Fund D - MarketBeat
Rhythm Pharmaceuticals (NASDAQ:RYTM) Insider Sells $323,753.15 in Stock - MarketBeat
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Investors Are Less Pessimistic Than Expected - 富途牛牛
Rhythm Pharmaceuticals Inc (RYTM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
                자본화:
                 
                  | 
                볼륨(24시간):